In this special VIDEO episode of “The Weekly Bioanalysis”, our experts, Dawn Dufield and Lindsay Rutherford have captured episode #103 LIVE and onsite in New Orleans during AAPS PharmSci360! They discuss all the things they have done during the conference and thank customers who were able to stop by…
In Episode #33 of The Conversational Flow, hosts Adam and Brian explore the latest developments in flow cytometry, immunology, and the evolving CRO industry. They examine new research into T-cell dynamics in graft-versus-host disease and regulatory T-cell stability, highlighting how flow cytometry and complementary technologies are advancing our understanding…
The main discussion in Episode #102 explores what KCAS Bio scientific advisors are hearing from customers as face-to-face visits and industry interactions increase. The conversation highlights a major shift toward more complex therapeutics and targeted delivery strategies, including conjugates, protein shuttles, in vivo gene therapies, and technologies designed to…
Episode #32 of The Conversational Flow explores several significant developments shaping the flow cytometry and biopharmaceutical industries, including advances in antibody drug conjugates (ADCs), questions surrounding circadian timing in cancer treatment, and major life sciences acquisitions. Our hosts, Brian and Adam, discuss how improvements in ADC linker technology and…
The main discussion in Episode #101 of “The Weekly Bioanalysis” focuses on how bioanalytical testing continues to evolve alongside increasingly complex drug modalities, with our co-hosts, Dom and John, exploring the technologies, methodologies, and regulatory trends shaping modern bioanalytical laboratories. They discuss how advances in mass spectrometry, including the…
In this special 100th episode of The Weekly Bioanalysis, hosts John Perkins and Dominic Warrino are joined on camera by KCAS Bio CEO John Bucksath and Chief Commercial Officer Amy Mize to celebrate a major milestone. Together, they reflect on the podcast’s origins during the uncertainty of the COVID-19…
Episode 31 of The Conversational Flow Podcast dives deep into some of the most exciting developments currently shaping the future of cell therapy, flow cytometry, and AI-driven drug development. Our hosts, Brian and Adam, discuss major advances in allogeneic and in vivo CAR-T therapies, including how new manufacturing platforms…
On this latest episode of The Weekly Bioanalysis podcast, Dom and John dive into one of the most pressing challenges in modern bioanalysis: how to break down silos and drive better project execution through continuity across teams. Drawing from real-world experience, they explore how the industry has evolved from…
The main discussion of this 30th episode of “The Conversational Flow” centers on automation in flow cytometry, focusing on a recent paper comparing three major sample preparation systems and their impact on efficiency, standardization, and error reduction. Our hosts, Adam and Brian, explore how automation can significantly reduce hands-on…
In the newest episode of “The Weekly Bioanalysis” podcast, our hosts, John and Dom welcome Scott Weir (Director, Institute for Advancing Medical Innovation at KU Medical Center) for a practical, behind-the-scenes look at how drug discovery and development can be executed in an academic setting—and what it takes to…
In episode #29 of “The Conversational Flow” podcast, our hosts, Brian and Adam, are joined by guests from Accelerating Cancer Immunotherapy Research (ACIR), a nonprofit dedicated to sharing important advances in cancer immunotherapy with the scientific community and the public. Ute Burkhardt discusses her background in cancer vaccines and…
In episode #97 of “The Weekly Bioanalysis” podcast, John and Dom focus on a review of 2025 drug approvals, revealing a surprisingly strong year for small molecules despite long-standing predictions of their decline. Of the 53 FDA approvals, 31 were small molecules, with additional complexity coming from ADCs and…